Carl Gustav Carus University Hospital, Dresden – Germany
About Prof. med. Dr. Esther Troost
Prof. med. Dr. Esther Troost is a senior German Radiation Oncologist with over 22 years of experience in image-guided high-precision radiotherapy and proton therapy. As Director of the Department of Radiotherapy and Radiation Oncology at University Hospital Dresden and Dean of TU Dresden's Faculty of Medicine, she is one of the most distinguished radiation oncology experts in Germany.
- 22+ years of experience in Radiation Oncology and Proton Therapy
- Director of the Department of Radiotherapy and Radiation Oncology, University Hospital Dresden
- Dean of the Faculty of Medicine — Carl Gustav Carus, TU Dresden
- Author of 349+ peer-reviewed scientific publications
- Recipient of the prestigious ESTRO Varian Award for clinically relevant research
Qualifications & Credentials
Medical Degrees
- Human Medicine — Eberhard Karls University Tübingen and Aberdeen Royal Infirmary (1998–2004)
- Postgraduate specialisation in Radiation Oncology — Maastricht University Medical Centre (MAASTRO Clinic), Netherlands
- Doctoral Degree (MD) — Medizinische Hochschule Hannover (Hannover Medical School), Germany
- Doctoral Degree — Radboud University Nijmegen, Netherlands
- Habilitation / Professor of Image-Guided High-Precision Radiotherapy — TU Dresden Faculty of Medicine (2015)
Fellowships & Special Training
- Specialist training in Radiation Oncology — Maastricht University Medical Centre / MAASTRO Clinic
- Specialist training in Proton Therapy — OncoRay National Center for Radiation Research in Oncology, Dresden
- Specialist training in Image-Guided Radiotherapy and Stereotactic Radiation Therapy
Certifications & Accreditations
- German Medical Association — Specialist Registration (Facharzt für Strahlentherapie / Radiation Oncology)
- European Society for Radiotherapy and Oncology (ESTRO) — Member
- European Society for Hyperthermic Oncology (ESHIMT) — Member
- German Cancer Consortium (DKTK) — Member
- National Center for Tumor Diseases (NCT) — Member
- EORTC Radiation Oncology Group — Member
- German Society for Radiation Oncology (DEGRO) — Member
- European Thoracic Oncology Group (ETOP) — Member
Areas of Expertise
Major Conditions Treated
- Lung Cancer (Including Stage III/IV NSCLC)
- Head & Neck Cancers
- Brain Tumours
- Breast Cancer
- Prostate Cancer
- Gastrointestinal Cancers
- Gynaecological Cancers
- Sarcomas
- Lymphomas
- Paediatric, Adolescent & Young Adult Cancers
- Recurrent Tumours Requiring Re-Irradiation
- Metastatic Cancers (SBRT for Oligometastases)
Sub-specialties
- Image-Guided High-Precision Radiotherapy: Adaptive radiation planning with real-time imaging guidance — a leading Radiation Oncologist specialist in Dresden, Germany for international patients seeking the most precise radiation therapy in Germany.
- Proton Therapy: Comprehensive particle therapy protocols at OncoRay, with a focus on adolescent and young adult cancers (KAYAC+ project) — relevant for international patients researching the best proton therapy in Germany.
- MR-Integrated Proton Therapy & Translational Radiotherapy: Pioneering MR-guided proton therapy research (MEDABIS-PRO project).
Advanced Procedures & Treatments
- Proton Therapy
- Image-Guided Radiation Therapy (IGRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Stereotactic Radiosurgery (SRS)
- Volumetric Modulated Arc Therapy (VMAT)
- Adaptive Radiation Therapy
- MR-Guided Proton Therapy (Research)
- FMISO-PET Hypoxia Imaging for Treatment Planning
- Radiation Therapy with Concurrent Chemotherapy (CRT)
List of Disease and Treatment for which Prof. med. Dr. Esther Troost can be consulted
Professional Experience
Current Affiliation
- Director — Department of Radiotherapy and Radiation Oncology, Carl Gustav Carus University Hospital Dresden, Germany (2019–Present)
- Dean — Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany (Present)
- Division Head — Image-Guided Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany (Present)
- Professor of Image-Guided High-Precision Radiotherapy — TU Dresden, Germany (2015–Present)
Past Affiliations
- Carl Gustav Carus University Hospital Dresden — Co-Chair, Department of Radiation Oncology and Proton Therapy (2019)
- Maastricht University, Netherlands — Assistant Professor, Department of Radiation Oncology (2014–2015)
- Maastricht University Medical Centre / MAASTRO Clinic, Netherlands — Radiation Oncologist (2012–2015)
Academic & Research Roles
- Dean of the Faculty of Medicine — TU Dresden
- Coordinator — KAYAC+ EU Project (Adolescents and Young Adults with Cancer, ~€1 million Pianoforte funding, 48 months)
- Project Lead — MEDABIS-PRO MR-integrated Proton Therapy Project (€1.1 million, 4 years, BMBF)
- Group Leader — Image-Guided High Precision Radiotherapy, OncoRay Institute
- Reviewer for major international scientific journals including Radiotherapy and Oncology, Radiation Oncology, Journal of Nuclear Medicine, and Nature Scientific Reports
Key Achievements
- 22+ years of experience in Radiation Oncology and Proton Therapy
- Director of Radiation Oncology and Dean of Medicine at TU Dresden — leading Germany's premier proton therapy programme
- Author of 349+ peer-reviewed scientific publications
- Recipient of the ESTRO Varian Award for clinically relevant research
- Coordinator of the EU KAYAC+ project on radiation therapy for adolescent and young adult cancers (€1 million)
- Co-coordinator of the BMBF MEDABIS-PRO MR-integrated proton therapy project (€1.1 million)
Awards & Recognitions
National & International Awards
- ESTRO Varian Award — European Society for Radiotherapy and Oncology, for clinically relevant and patient-oriented research
- EU Pianoforte Funding (~€1 million) — KAYAC+ project, 2025
- BMBF Funding (€1.1 million) — MEDABIS-PRO MR-integrated proton therapy project
Professional Memberships
- European Society for Radiotherapy and Oncology (ESTRO)
- European Society for Hyperthermic Oncology (ESHIMT)
- German Cancer Consortium (DKTK)
- National Center for Tumor Diseases (NCT)
- EORTC Radiation Oncology Group
- German Society for Radiation Oncology (DEGRO)
- German Roentgen Society (DRG)
- Dutch Society for Radiation Oncology (NVRO)
- European Thoracic Oncology Group (ETOP)
Research & Publications
Published Papers (Selected)
- Author of 349+ peer-reviewed scientific publications in international high-ranking radiation oncology journals.
- Kotzerke J, Troost EGC, Zips D, Baumann M. "Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging." Radiotherapy and Oncology. 2017;124(3):533–540.
- Coordinator and senior author on multiple papers in the KAYAC+ adolescent and young adult cancer radiation therapy programme.
- Multiple publications on image-guided high-precision radiotherapy, proton therapy and MR-guided particle therapy.
Ongoing Research & Clinical Interests
- Image-guided high-precision radiotherapy
- Proton therapy and particle therapy outcomes
- MR-integrated proton therapy (MRiPT)
- Adolescent and young adult cancer radiotherapy (KAYAC+)
- Adaptive radiation planning and personalised radiotherapy
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Radiation Oncology Consultation (Germany) | ₹15,000 – ₹30,000 | $180 – $360 |
| Proton Therapy (Course of Treatment) | ₹40,00,000 – ₹85,00,000 | $48,000 – $1,02,000 |
| IMRT / VMAT (Course of Treatment) | ₹12,00,000 – ₹25,00,000 | $14,400 – $30,000 |
| Stereotactic Body Radiation Therapy (SBRT) | ₹15,00,000 – ₹30,00,000 | $18,000 – $36,000 |
| Stereotactic Radiosurgery (SRS) | ₹15,00,000 – ₹30,00,000 | $18,000 – $36,000 |
| Re-Irradiation (Recurrent Tumours) | ₹15,00,000 – ₹35,00,000 | $18,000 – $42,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. med. Dr. Esther Troost use in Radiation Oncologist treatment?
Prof. Esther Troost uses the most advanced radiation oncology technologies including proton therapy, MR-guided proton therapy, image-guided radiotherapy (IGRT), intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and adaptive radiation planning with real-time imaging guidance. Virtual second opinions are also available for international patients seeking expert radiation oncology care in Germany.
2. What conditions does Prof. med. Dr. Esther Troost specialize in treating?
Prof. Esther Troost specialises in radiation therapy for lung cancer, head and neck cancers, brain tumours, breast cancer, prostate cancer, gastrointestinal cancers, gynaecological cancers, sarcomas, lymphomas, and paediatric, adolescent and young adult cancers — making her a leading Radiation Oncologist specialist in Dresden, Germany for international cancer patients.
3. How do I book an appointment with Prof. med. Dr. Esther Troost?
Appointments with Prof. med. Dr. Esther Troost can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. med. Dr. Esther Troost?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. med. Dr. Esther Troost, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. med. Dr. Esther Troost offer second opinions for Radiation Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Radiation Oncologist specialist in Dresden, Germany — particularly relevant for proton therapy, head-and-neck cancers, and adolescent and young adult cancer cases.
Carl Gustav Carus University Hospital, Dresden - Germany
